Life Science Company News

Reset
Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Atsena Therapeutics, Inc.

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  MDxHealth

Aeterna Zentaris Announces Effective Date of Share Consolidation

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  AEterna Zentaris Inc.

Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Catalyst Pharmaceuticals, Inc.

4DMT Announces Presentations at ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  4D Molecular Therapeutics, Inc.

Inovalon Earns 2024 Great Place To Work® Certification™ For Second Consecutive Year

Read more ››
By: GlobeNewswire - 01 May 2024

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Corbus Pharmaceuticals Holdings, Inc.

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Benitec Biopharma Inc.

ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  ImmuneSensor Therapeutics, Inc

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Denali Therapeutics Inc.

BetterLife Advances BETR-001 IND-enabling Studies

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  BetterLife Pharma Inc.

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Annexon, Inc. | Annexin Pharmaceuticals AB (publ)

AltruBio to Participate in Upcoming May 2024 Medical Conferences

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  AltruBio Inc.

Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officer

Read more ››
By: GlobeNewswire - 01 May 2024

PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  PharmaTher Holdings Ltd.

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Editas Medicine, Inc.

Touro University Nevada College of Osteopathic Medicine Teaches Living Anatomy and Physiology with Vave Health Pocket Ultrasound

Read more ››
By: GlobeNewswire - 01 May 2024

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Ardelyx, Inc

Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Cocrystal Pharma, Inc.

Pliant Therapeutics to Participate in Upcoming Investor Events

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Pliant Therapeutics, Inc.
Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »